Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.
Tabernero J, Alsina M, Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Ando T, Yalçın Ş, Van Cutsem E, Sabater J, Skanji D, Leger C, Amellal N, Ilson DH. Tabernero J, et al. Among authors: nishikawa k. Gastric Cancer. 2020 Jul;23(4):689-698. doi: 10.1007/s10120-020-01053-9. Epub 2020 Mar 4. Gastric Cancer. 2020. PMID: 32128634 Free PMC article. Clinical Trial.
Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis.
Shitara K, Morita S, Fujitani K, Kadowaki S, Takiguchi N, Hirabayashi N, Takahashi M, Takagi M, Tokunaga Y, Fukushima R, Munakata Y, Nishikawa K, Takagane A, Tanaka T, Sekishita Y, Sakamoto J, Tsuburaya A. Shitara K, et al. Among authors: nishikawa k. Gastric Cancer. 2012 Jul;15(3):245-51. doi: 10.1007/s10120-011-0101-x. Epub 2011 Oct 13. Gastric Cancer. 2012. PMID: 21993850 Free PMC article. Clinical Trial.
A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer.
Nishikawa K, Morita S, Matsui T, Kobayashi M, Takeuchi Y, Takahashi I, Sato S, Miyashita Y, Tsuburaya A, Sakamoto J, Kakeji Y, Baba H. Nishikawa K, et al. Gastric Cancer. 2012 Oct;15(4):363-9. doi: 10.1007/s10120-011-0124-3. Epub 2012 Jan 26. Gastric Cancer. 2012. PMID: 22278377 Clinical Trial.
[Chemotherapy for gastric cancer patients over 75 years of age].
Kawada J, Matsuura N, Kitagawa A, Nishimura M, Nomura M, Okumura Y, Miyazaki S, Danno K, Kubota M, Matsuda C, Omori K, Nishikawa K, Nomura M, Takagi M, Fukui A, Fujitani K, Iwase K, Tanaka Y. Kawada J, et al. Among authors: nishikawa k. Gan To Kagaku Ryoho. 2014 Nov;41(12):2248-50. Gan To Kagaku Ryoho. 2014. PMID: 25731485 Japanese.
Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
Matsusaka S, Nashimoto A, Nishikawa K, Miki A, Miwa H, Yamaguchi K, Yoshikawa T, Ochiai A, Morita S, Sano T, Kodera Y, Kakeji Y, Sakamoto J, Saji S, Yoshida K. Matsusaka S, et al. Among authors: nishikawa k. Gastric Cancer. 2016 Jul;19(3):839-51. doi: 10.1007/s10120-015-0518-8. Epub 2015 Aug 12. Gastric Cancer. 2016. PMID: 26265390 Free PMC article.
Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy.
Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Nagatsuma Y, Nakayama T, Tanikawa S, Maeda S, Uemura M, Miyake M, Hama N, Miyamoto A, Ikeda M, Nakamori S, Sekimoto M, Fujitani K, Tsujinaka T. Fukuda Y, et al. Among authors: nishikawa k. Gastric Cancer. 2016 Jul;19(3):986-93. doi: 10.1007/s10120-015-0546-4. Epub 2015 Sep 25. Gastric Cancer. 2016. PMID: 26407875
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.
Bando H, Yamada Y, Tanabe S, Nishikawa K, Gotoh M, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Hamada C, Hyodo I. Bando H, et al. Among authors: nishikawa k. Gastric Cancer. 2016 Jul;19(3):919-26. doi: 10.1007/s10120-015-0549-1. Epub 2015 Oct 16. Gastric Cancer. 2016. PMID: 26474989 Clinical Trial.
Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin.
Nishikawa K, Yamada Y, Ishido K, Gotoh M, Bando H, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Hamada C, Hyodo I. Nishikawa K, et al. Gastric Cancer. 2017 Jul;20(4):640-645. doi: 10.1007/s10120-016-0666-5. Epub 2016 Nov 7. Gastric Cancer. 2017. PMID: 27822684 Clinical Trial.
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
Shitara K, Takashima A, Fujitani K, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Makari Y, Amagai K, Ueda S, Yoshida K, Shimodaira H, Nishina T, Tsuda M, Kurokawa Y, Tamura T, Sasaki Y, Morita S, Koizumi W. Shitara K, et al. Among authors: nishikawa k. Lancet Gastroenterol Hepatol. 2017 Apr;2(4):277-287. doi: 10.1016/S2468-1253(16)30219-9. Epub 2017 Jan 19. Lancet Gastroenterol Hepatol. 2017. PMID: 28404157 Clinical Trial.
2,237 results